Male +
Natural health product licensed in Canada
- Licence holder
- Viatrexx (8046255 Canada Inc)
- NPN or DIN-HM
- 80057233
- Status
- Active licence
- Licence date
- 13 January 2015
- Revision date
- 21 January 2015
- Form
- Vaporisateur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sus scrofa Source : Hypophyse | 200 K | Not calculated |
| Sus scrofa Source : Thalamus | 6 X | Not calculated |
| Sus scrofa Source : Hypothalamus | 6 X | Not calculated |
| Sus scrofa Source : Glande surrénale | 200 K | Not calculated |
| Sus scrofa Source : Prostate | 200 K | Not calculated |
| Sus scrofa Source : Thymus | 200 K | Not calculated |
| Sus scrofa Source : Glande pinéale | 6 X | Not calculated |
| Sus scrofa Source : Testicule | 200 K | Not calculated |
| Sus scrofa Source : Glande thyroïde | 6 X | Not calculated |
| Sus scrofa Source : Glande thyroïde | 200 K | Not calculated |
| Sus scrofa Source : Thalamus | 200 K | Not calculated |
| Cholesterinum Source : Cholestérol d'animaux supérieurs trouvé dans les tissus, cerveau, moelle épinière, graisse, bile et calculs biliaires | 6 X | Not calculated |
| Sus scrofa Source : Pancréas | 200 K | Not calculated |
| Cyclic adenosine monophosphate Source : Cyclic adenosine monophosphate | 6 X | Not calculated |
| Sus scrofa Source : Glande surrénale | 6 X | Not calculated |
| Cyclic adenosine monophosphate Source : Cyclic adenosine monophosphate | 200 K | Not calculated |
| Cholesterinum Source : Cholestérol d'animaux supérieurs trouvé dans les tissus, cerveau, moelle épinière, graisse, bile et calculs biliaires | 200 K | Not calculated |
| Sus scrofa Source : Hypothalamus | 200 K | Not calculated |
| Sus scrofa Source : Pancréas | 6 X | Not calculated |
| Sus scrofa Source : Glande pinéale | 200 K | Not calculated |
| Sus scrofa Source : Hypophyse | 6 X | Not calculated |
| Sus scrofa Source : Prostate | 6 X | Not calculated |
| Sus scrofa Source : Testicule | 6 X | Not calculated |
| Sus scrofa Source : Thymus | 6 X | Not calculated |
Non-medicinal ingredients
Alcool 20%, Eau distillée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et enfants | minimum: 13 years | minimum: 1 Pulvérisateur ; maximum: 5 Pulvérisateur | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Organotherapy & homeopathic preparation
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80057233
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2015. Photograph the packaging to check whether it has changed. Photograph the packaging